↓ Skip to main content

American Association for Cancer Research

An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML

Overview of attention for article published in Cancer Discovery, September 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
41 X users

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
100 Mendeley
Title
An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML
Published in
Cancer Discovery, September 2021
DOI 10.1158/2159-8290.cd-20-1851
Pubmed ID
Authors

Shan Lin, Clément Larrue, Nastassja K. Scheidegger, Bo Kyung A. Seong, Neekesh V. Dharia, Miljan Kuljanin, Caroline S. Wechsler, Guillaume Kugener, Amanda L. Robichaud, Amy Saur Conway, Thelma Mashaka, Sarah Mouche, Biniam Adane, Jeremy A. Ryan, Joseph D. Mancias, Scott T. Younger, Federica Piccioni, Lynn H. Lee, Mark Wunderlich, Anthony Letai, Jérôme Tamburini, Kimberly Stegmaier

X Demographics

X Demographics

The data shown below were collected from the profiles of 41 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 100 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 11%
Student > Bachelor 8 8%
Researcher 8 8%
Student > Master 5 5%
Student > Doctoral Student 3 3%
Other 9 9%
Unknown 56 56%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 18 18%
Medicine and Dentistry 6 6%
Agricultural and Biological Sciences 5 5%
Unspecified 3 3%
Mathematics 1 1%
Other 6 6%
Unknown 61 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2023.
All research outputs
#1,228,247
of 25,734,859 outputs
Outputs from Cancer Discovery
#631
of 4,153 outputs
Outputs of similar age
#27,928
of 423,375 outputs
Outputs of similar age from Cancer Discovery
#20
of 66 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,153 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.2. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,375 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.